Rapid Intracranial Clot Removal with a New Device: The Alligator Retriever

References

1. ↵
   Brott TG, Haley EC Jr, Levy DE, et al. Urgent therapy for stroke. Part I. Pilot study of tissue plasminogen activator administered within 90 minutes. Stroke 1992;23:632–40

   Abstract/FREE Full Text
2. ↵
   Haley EC Jr, Levy DE, Brott TG, et al. Urgent therapy for stroke. Part II. Pilot study of tissue plasminogen activator administered 91–180 minutes from onset. Stroke 1992;23:641–45

   Abstract/FREE Full Text
3. ↵
   Scott P. Management of acute ischemic stroke. Semin Respir Crit Care Med 2002;23:69–81

   PubMed
4. ↵
   Devuyst G, Bogousslavsky J. Recent progress in drug treatment for acute ischemic stroke. Cerebrovasc Dis 2001;11(suppl 1):71–79
5. ↵
   Halloran, JI, Bekavac I. Unsuccessful tissue plasminogen activator treatment of acute stroke caused by a calcific embolus. J Neuroimaging 2004;14:385–87

   CrossRefPubMedWeb of Science
6. ↵
   Kerber CW, Bair JD, Berger RM. et al. Snare retrieval of intracranial thrombus in patients with acute stroke. J Vasc Interv Radiol 2002;13:1269–74

   PubMedWeb of Science
7. ↵
   Chopko BW, Kerber C, Wong W, et al. Transcatheter snare removal of acute middle cerebral artery thromboembolism: technical case report. Neurosurgery 2000;46:1529–31

   CrossRefPubMedWeb of Science
8. ↵
   Tissue plasminogen activator for acute ischemic stroke: The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. N Engl J Med 1995;333:1581–87

   CrossRefPubMedWeb of Science
9. ↵
   Kothari RU, Brott T, Broderick JP, et al. Emergency physicians: accuracy in the diagnosis of stroke. Stroke 1995;26:2238–41

   Abstract/FREE Full Text
10. ↵
    Hacke W, Kaste M, Fieschi C, et al. Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II): Second European-Australasian Acute Stroke Study Investigators. Lancet 1998;352:1245–51

    CrossRefPubMedWeb of Science
11. ↵
    Clark WM, Wissman S, Albers GW, et al. Recombinant tissue-type plasminogen activator (Alteplase) for ischemic stroke 3 to 5 hours after symptom onset: The ATLANTIS Study—a randomized controlled trial. Alteplase Thrombolysis for Acute Noninterventional Therapy in Ischemic Stroke. JAMA 1999;282:2019–26

    CrossRefPubMedWeb of Science
12. ↵
    Tomsick T, Brott T, Barsan W, et al. Thrombus localization with emergency cerebral CT. AJNR Am J Neuroradiol 1992;13:257–63

    Abstract/FREE Full Text
13. ↵
    Tomsick T, Brott T, Barsan W, et al. Prognostic value of the hyperdense middle cerebral artery sign and stroke scale score before ultraearly thrombolytic therapy. AJNR Am J Neuroradiol 1996;17:79–85

    Abstract